As of January 2023, our "Journal of Controversies Obstetrics & Gynecology and Pediatrics" has been published under the Medihealth Academy to publish all articles, reviews and case reports on Pediatrics, especially in the field of Obstetrics and Gynecology. In order to facilitate the citation of the articles, to take our place in internationally respected indexes and to reach a wider readership, we will pay attention to the fact that our article language is only English in terms of acceptance.

EndNote Style
Original Article
The relationship between prolactin level and inflammatory markers in women with polycystic ovary syndrome
Aims: This study aimed to investigate the relationship between prolactin (PRL) levels and inflammatory markers in women with polycystic ovary syndrome (PCOS) compared to controls..
Methods: A total of 120 women, 60 with PCOS and 60 controls, were included in this study. The participants were divided into four groups based on their PRL levels: hyperprolactinemia PCOS, normal PRL PCOS, hyperprolactinemia controls, and normal PRL controls. The levels of various inflammatory markers, including C-reactive protein (CRP), Hb, red cell distribution width (RDW-SD), mean platelet volume (MPV), and platelet distribution width (PDW), were measured and compared between the groups. The correlation between PRL levels and inflammatory markers was also analyzed.
Results: The results show that the mean value of CRP was higher in the PCOS group with hyperprolactinemia (2.15±1.61) compared to the PCOS group with normal PRL levels (1.68±1.19), but the difference was not statistically significant (p=0.432). The correlation results show that there was a statistically significant negative correlation between PRL levels and Hb (r=-0.313, p=0.015) and a positive correlation between PRL levels and RDW-SD (r=0.352, p=0.006) in PCOS patients. In PCOS patients, higher PRL levels were associated with increased RDW-SD, decreased Hb levels, decreased platelet count, and increased MPV and PDW. However, there was no significant correlation between PRL levels and inflammatory markers in the control group.
Conclusion: The results of this study suggest that higher PRL levels may be associated with increased inflammation in PCOS patients. However, further research is needed to understand the underlying mechanisms and potential clinical implications of these associations.

1. Alanya Tosun Ş, Gurbuz T, Cebi A, Tosun A, Gokmen O, Usta M.Association of increased levels of omentin-1 and carotid intima-mediathickness with early signs of cardiovascular risk in patients withpolycystic ovary syndrome: a prospective case control study. J ObstetGynaecol Res. 2022;48(1):169-177. doi:10.1111/jog.15077
2. Asfuroğlu Y, Kan Ö, Asfuroğlu M, Baser E. Association between dryeye and polycystic ovary syndrome: subclinical inflammation may bepart of the process. Eye Contact Lens. 2021;47(1):27-31. doi:10.1097/ICL.0000000000000716
3. Barbakadze L, Kristasashvili J. Antimullerian hormone in cases of differentreproductive pathologies. Georgian Med News. 2014;(232-233):16-21.
4. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus WorkshopGroup. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril.2004;81(1):19-25. doi:10.1016/j.fertnstert.2003.10.004
5. Dokuzeylül Güngör N, Güngör K, Yurci A, Cil K, Hatırnaz Ş. Ovariandrilling down-regulates endometrial nuclear factor-κB p65 expressionin women with PCOS: a prospective case-control study. Turk J ObstetGynecol. 2022;19(1):45-50. doi:10.4274/tjod.galenos.2022.44845
6. Gungor ND, Gurbuz T. Pregnancy outcomes of intrauterineinsemination in age-matched young women according to serum anti-mullerian hormone levels. JRM. 2021;66:195-202.
7. Güngör ND, Gürbüz T. Prediction of the number of oocytes based onAMH and FSH levels in IVF candidates. J Surg Med. 2020;4:733-737.doi:10.28982/josam.759207.
8. Gürbüz T, Gökmen O, Demirçivi Bör E, Uluocak A. Investigating therelationship of serum levels of afamin and interleukin-10 with insulinresistance in infertile women with polycystic ovary syndrome. J SurgMed. 2021;5(3):264-268. doi:10.28982/josam.874039.
9. Gürbüz T, Gökmen O, Dokuzeylül Güngör N. Polikistik over sendromubulunan kadınlarda glikoz potasyum oranının tanısal değerinininsülin ile karşılaştırılması . Cukurova Med J. 2021;46(1):381-386. doi.org/10.17826/cumj.782931
10. Gurbuz T, Gokmen O. A Novel Index to overcome the assessmentlimitations of insulin resistance in polycystic ovary syndromehomeostatic model assessment index to red blood cell distributionwidth ratio. JRM. 2021;66(1-2):9-14.
11. Overgaard M, Glintborg D, Christesen HT, Jensen TK, Andersen MS.Maternal prolactin is associated with glucose status and PCOS inpregnancy: odense child cohort. Eur J Endocrinol. 2020;183(3):307-316.doi:10.1530/EJE-20-0144
12. Rudnicka E, Kunicki M, Suchta K, Machura P, Grymowicz M, SmolarczykR. Inflammatory markers in women with polycystic ovary syndrome.Biomed Res Int. 2020;2020:4092470. doi:10.1155/2020/4092470
13. Han Y, Kim HS, Lee HJ, Oh JY, Sung YA. Metabolic effects of polycystic ovarysyndrome in adolescents. Ann Pediatr Endocrinol Metab. 2015;20(3):136-142.doi:10.6065/apem.2015.20.3.136
14. Yilmaz Ö, Calan M, Kume T, Temur M, Yesil P, Senses MY. The effect ofprolactin levels on MPV in women with PCOS. Clin Endocrinol (Oxf).2015;82(5):747-752. doi:10.1111/cen.12647
15. Li L, Yu J, Zhou Z. Mean platelet volume and polycystic ovarysyndrome: a systematic review and meta-analysis. J Int Med Res. 2022;50(1):3000605211067316. doi:10.1177/03000605211067316
16. Yilmaz Ö, Mehmet C, Kelekci S, Temur M. Association between redblood cell distribution width and polycystic ovary syndrome. EndocrRes. 2015;40(4):181-187. doi:10.3109/07435800.2014.987398
17. Saei Ghare Naz M, Mousavi M, Mahboobifard F, Niknam A, RamezaniTehrani F. A meta-analysis of observational studies on prolactinlevels in women with polycystic ovary syndrome. Diagnostics (Basel).2022;12(12):2924. doi:10.3390/diagnostics12122924
Volume 1, Issue 4, 2023
Page : 80-84